Increased level of Oct-1 protein in tumor cells modulates cellular response to anticancer drugs
- Authors: Portseva T.N.1, Pankratova E.V.1, Stepchenko A.G.1, Georgieva S.G.1
-
Affiliations:
- Engelhardt Institute of Molecular Biology
- Issue: Vol 469, No 1 (2016)
- Pages: 269-272
- Section: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journal-vniispk.ru/1607-6729/article/view/211410
- DOI: https://doi.org/10.1134/S1607672916040098
- ID: 211410
Cite item
Abstract
The effect of overexpression of Oct-1 protein isoforms on the cell response to two anticancer drugs camptothecin and dexamethasone was studied. The effect of Oct-1 isoforms on regulated gene transcription was estimated by the difference in the level of mRNA in Burkitt’s lymphoma cells (Namalwa line) untransfected and stably transfected with Oct-1 isoforms. The response to anticancer drugs of the Oct-1 target genes involved in the development of apoptosis depended, firstly, on the type of drug, secondly, on the concentration of Oct-1 in cells. and, thirdly, on the Oct-1 isoform with which these cells were transfected.
About the authors
T. N. Portseva
Engelhardt Institute of Molecular Biology
Author for correspondence.
Email: tanjnij86@mail.ru
Russian Federation, ul. Vavilova 32, Moscow, 119991
E. V. Pankratova
Engelhardt Institute of Molecular Biology
Email: tanjnij86@mail.ru
Russian Federation, ul. Vavilova 32, Moscow, 119991
A. G. Stepchenko
Engelhardt Institute of Molecular Biology
Email: tanjnij86@mail.ru
Russian Federation, ul. Vavilova 32, Moscow, 119991
S. G. Georgieva
Engelhardt Institute of Molecular Biology
Email: tanjnij86@mail.ru
Russian Federation, ul. Vavilova 32, Moscow, 119991
Supplementary files
